About this episode

The episode discusses novel therapies for myasthenia gravis and their potential to address unmet patient needs.

What is lacking in the care of your patients with myasthenia gravis? Find out how novel pathology-targeting therapies can meet unmet needs. Credit available for this activity expires: 5/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/what-lies-beneath-generalized-myasthenia-gravis-exploring-2026a1000fuh?ecd=bdc_podcast_libsyn_mscpedu

Topics covered

• myasthenia gravis
• novel therapies
• patient care
• pathology-targeting
• unmet needs

Keywords

• myasthenia gravis
• therapies
• patient care
• novel mechanisms
• pathology-targeting

Mentioned in this episode

Organizations: Medscape

Books & works: What Lies Beneath Generalized Myasthenia Gravis

More episodes of Keeping Current

• Pharmacological and Combination Interventions for Nicotine Cessation · June 30, 2026 · 33 min
• Is Normalizing Hemostasis an Achievable Goal in Hemophilia A? · June 26, 2026 · 30 min
• The Top 5 Errors in Transthyretin Amyloid Cardiomyopathy Management · June 26, 2026 · 18 min
• Better Drying? Longer Lasting? Second-Generation Anti-VEGF Therapies in Clinical Practice · June 23, 2026 · 37 min
• Shaping the Future of Precision Oncology: Biomarker-Driven Care for Tumor-Agnostic Therapies · June 17, 2026 · 23 min
• Navigating the Management of Alagille Syndrome Using Ileal Bile Acid Transporter (IBAT) Inhibitors · June 17, 2026 · 22 min

Explore listener stats, chart rankings, contacts and more on the Keeping Current podcast page.